definiens: shall mean ( a ) the specific proprietary E. coli [ * * * ] strain of Wacker Biotech in an unmodified form and which has been se lected by Wacker Biotech from ESETEC ® in course of the Preceding Service Agreements as the basis fo r the construction of the Developed Strain(s ), or ( b ) any specific modified or improved strain that may be de veloped by Wacker Biotech pursuant to a new statement of work under the [COMPANY] DCSA to be mut ually agreed by the Parties, or a future agreement between the Parties, as the basis for the construct ion of Developed Strain(s ) . For the sake of clarity, the term as used in this Agre ement shall expressly not comprise ( i ) any contributions ( either material or immaterial ) of Me dImmune or [COMPANY] under the Preceding Service Agreements, including, in each case, genetic materi al or information coding for Product, [COMPANY] Background IP and/or [COMPANY] Material ; or ( ii ) any combinations of such contributions of MedImmune and/or [COMPANY] under the Preceding Service Agreeme nts with such specific proprietary E. coli [ * * * ] strain . The term as used in this Agreement is strictly limited to the specif ic proprietary E. coli [ * * * ] strain described in clause ( a ) of the first sentence of this Section 1.57 as such, or a specific modified or improved strain described in c lause ( b ) of the first sentence of this Section 1.5 7 as such ; which strain, in each case ( ( a ) and ( b ) ), doe s not contain genetic information coding for Produc t. For clarity, the WACKER Secretion Strain as such is not able to produce or secrete Product since it does n ot contain genetic information coding for Product